Early stage molecular profiling
19 Jul 2011
Early stage molecular profiling
WIN 2011: Personalised medicine and a global biomarker database
Emergence of ipilimumab and vemurafenib for melanoma
Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life
The P-Medicine project; data sharing and integration for personalised medicine
Patient non-compliance to treatment schedules
VTD consolidation therapy for multiple myeloma
Dasatinib therapy for CML patients unsuitable for imatinib
Key CLL research from EHA 2011
Patient advocacy session on treatment adherence
Latest advances in multiple myeloma
Advances in CLL treatment